Why the study?
Does KRH-594 prevent end-organ damage and improve survival in salt-loaded stroke-prone spontaneously hypertensive rats?
Population
salt-loaded stroke-prone spontaneously hypertensive rats (SHRSP/Izm)
Design
Preclinical
Follow-up
11 weeks
Authors
Loading...
Does not inform clinical practice; leaves open translation of KRH-594 benefits to human hypertensive disease.
Does KRH-594 prevent end-organ damage and improve survival in salt-loaded stroke-prone spontaneously hypertensive rats?
KRH-594, a novel AT1 receptor antagonist, demonstrates protective effects against hypertensive end-organ damage and mortality in a preclinical rat model.
Inada et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: